Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.76 USD | +0.21% | +4.85% | -8.99% |
May. 15 | Eagle Pharmaceuticals, Inc. Enters into a Third Amendment to Third Amended and Restated Credit Agreement | CI |
May. 06 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2021 | 172M | Sales 2022 | 317M | Capitalization | 380M |
---|---|---|---|---|---|
Net income 2021 | -8M | Net income 2022 | 35M | EV / Sales 2021 | 3.44 x |
Net cash position 2021 | 67.84M | Net Debt 2022 | 10.19M | EV / Sales 2022 | 1.23 x |
P/E ratio 2021 |
-77
x | P/E ratio 2022 |
10.7
x | Employees | 134 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 65.14% |
Latest transcript on Eagle Pharmaceuticals, Inc.
1 day | +0.21% | ||
1 week | +4.85% | ||
Current month | +16.38% | ||
1 month | +6.25% | ||
3 months | -20.27% | ||
6 months | -46.99% | ||
Current year | -8.99% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Graves
CEO | Chief Executive Officer | 61 | 13-10-31 |
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 07-02-28 |
Ryan Debski
CMP | Compliance Officer | - | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 07-02-28 |
Jennifer Simpson
BRD | Director/Board Member | 55 | 19-08-27 |
Richard Edlin
BRD | Director/Board Member | 63 | 17-03-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.54% | 28 M€ | -0.48% | ||
0.25% | 25 M€ | -1.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 4.76 | +0.21% | 68,384 |
24-05-16 | 4.75 | +3.04% | 125,668 |
24-05-15 | 4.61 | -1.28% | 56,288 |
24-05-14 | 4.67 | +3.78% | 62,535 |
24-05-13 | 4.5 | -0.88% | 246,295 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-8.99% | 61.82M | |
+16.03% | 79.03B | |
+10.23% | 8.96B | |
-10.76% | 5.19B | |
+51.58% | 4.77B | |
+12.50% | 4.26B | |
-20.70% | 2.37B | |
+12.83% | 2.3B | |
-29.65% | 2.21B | |
+19.51% | 2.17B |
- Stock Market
- Equities
- EGRX Stock